Inventor
GEORGE KENNETH LLOYD
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
A61NElectrotherapy13%
C07KPeptides7%
PatentTitleYear
12,458,638Method of stimulating neutrophil survival and reducing neutropenia202512,433,886Composition and method for reducing neutropenia202511,857,522Compositions containing tucaresol or its analogs202411,786,523Composition and method for reducing thrombocytopenia202311,400,086Method of reducing chemotherapy-induced neutropenia202211,229,642Composition and method for reducing neutropenia2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BEYONDSPRING PHARMACEUTICALS INC (6)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BEYONDSPRING PHARMACEUTICALS INC | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |